Role of fibroblasts in the pathogenesis of atopic dermatitis

Journal of Allergy and Clinical Immunology

Volumn 131, Issue 6, 2013, Pages

  Berroth, Andreas ^a   Kühnl, Jochen ^a   Kurschat, Nina ^a   Schwarz, Agatha ^b   Stäb, Franz ^a   Schwarz, Thomas ^b   Wenck, Horst ^a   Fölster Holst, Regina ^b   Neufang, Gitta ^a  

^a BEIERSDORF AG   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

Author keywords

Atopic dermatitis; differentiation; fibroblast; keratinocyte; leukemia inhibitory factor; organotypic culture; stratification

Indexed keywords

CYTOKERATIN 10; CYTOKERATIN 5; FILAGGRIN; INVOLUCRIN; LEUKEMIA INHIBITORY FACTOR; LEUKEMIA INHIBITORY FACTOR RECEPTOR; LORICRIN; SUPPRESSOR OF CYTOKINE SIGNALING 3;

ADULT; ARTICLE; ATOPIC DERMATITIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; EPIDERMIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN FIBROBLAST;

EID: 84878602448     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2013.02.029     Document Type: Article

References (45)

1. B. Korge [Epidermal barrier function abnormalities in atopic dermatitis caused by filaggrin mutations] Hautarzt 60 2009 522
2. J.A. McGrath Filaggrin and the great epidermal barrier grief Australas J Dermatol 49 2008 67 74
3. C.N. Palmer, A.D. Irvine, A. Terron-Kwiatkowski, Y. Zhao, H. Liao, and S.P. Lee Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis Nat Genet 38 2006 441 446
4. A. De Benedetto, N.M. Rafaels, L.Y. McGirt, A.I. Ivanov, S.N. Georas, and C. Cheadle Tight junction defects in patients with atopic dermatitis J Allergy Clin Immunol 127 2010 773 786.e1-7
5. N. Kirschner, P. Houdek, M. Fromm, I. Moll, and J.M. Brandner Tight junctions form a barrier in human epidermis Eur J Cell Biol 89 2010 839 842
6. M. Suarez-Farinas, S.J. Tintle, A. Shemer, A. Chiricozzi, K. Nograles, and I. Cardinale Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalities J Allergy Clin Immunol 127 2011 954 964 e1-4
7. A. El Ghalbzouri, P. Hensbergen, S. Gibbs, J. Kempenaar, R. van der Schors, and M. Ponec Fibroblasts facilitate re-epithelialization in wounded human skin equivalents Lab Invest 84 2004 102 112
8. R.M. Grossman, J. Krueger, D. Yourish, A. Granelli-Piperno, D.P. Murphy, and L.T. May Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes Proc Natl Acad Sci U S A 86 1989 6367 6371
9. N. Maas-Szabowski, A. Shimotoyodome, and N.E. Fusenig Keratinocyte growth regulation in fibroblast cocultures via a double paracrine mechanism J Cell Sci 112 suppl 1999 1843 1853
10. H. Smola, G. Thiekotter, M. Baur, H.J. Stark, D. Breitkreutz, and N.E. Fusenig Organotypic and epidermal-dermal co-cultures of normal human keratinocytes and dermal cells: Regulation of transforming growth factor alpha, beta1 and beta2 mRNA levels Toxicol In Vitro 8 1994 641 650
11. H. Smola, G. Thiekotter, and N.E. Fusenig Mutual induction of growth factor gene expression by epidermal-dermal cell interaction J Cell Biol 122 1993 417 429
12. R.A. Tupker, J. Pinnagoda, P.J. Coenraads, and J.P. Nater Susceptibility to irritants: role of barrier function, skin dryness and history of atopic dermatitis Br J Dermatol 123 1990 199 205
13. S.H. Lee, S.K. Jeong, and S.K. Ahn An update of the defensive barrier function of skin Yonsei Med J 47 2006 293 306
14. N. Morar, S.A. Willis-Owen, M.F. Moffatt, and W.O. Cookson The genetics of atopic dermatitis J Allergy Clin Immunol 118 2006 24 36
15. M.J. Cork, S.G. Danby, Y. Vasilopoulos, J. Hadgraft, M.E. Lane, and M. Moustafa Epidermal barrier dysfunction in atopic dermatitis J Invest Dermatol 129 2009 1892 1908
16. E. Proksch, R. Folster-Holst, and J.M. Jensen Skin barrier function, epidermal proliferation and differentiation in eczema J Dermatol Sci 43 2006 159 169
17. A. De Benedetto, R. Agnihothri, L.Y. McGirt, L.G. Bankova, and L.A. Beck Atopic dermatitis: a disease caused by innate immune defects? J Invest Dermatol 129 2009 14 30
18. Y. Yamaguchi, T. Passeron, T. Hoashi, H. Watabe, F. Rouzaud, and K. Yasumoto Dickkopf 1 (DKK1) regulates skin pigmentation and thickness by affecting Wnt/beta-catenin signaling in keratinocytes FASEB J 22 2008 1009 1020
19. A.J. Singer, and R.A. Clark Cutaneous wound healing N Engl J Med 341 1999 738 746
20. S. Werner, and R. Grose Regulation of wound healing by growth factors and cytokines Physiol Rev 83 2003 835 870
21. P. Saiag, B. Coulomb, C. Lebreton, E. Bell, and L. Dubertret Psoriatic fibroblasts induce hyperproliferation of normal keratinocytes in a skin equivalent model in vitro Science 230 1985 669 672
22. G.G. Krueger, and C.M. Jorgensen Experimental models for psoriasis J Invest Dermatol 95 1990 56S 58S
23. H. Ishikawa, Y. Mitsuhashi, Y. Takagi, and I. Hashimoto Psoriatic fibroblasts enhance cornified envelope formation in normal keratinocytes in vitro Arch Dermatol Res 289 1997 551 553
24. J.H. Lee, S.Y. Chen, C.H. Yu, S.W. Chu, L.F. Wang, and C.K. Sun Noninvasive in vitro and in vivo assessment of epidermal hyperkeratosis and dermal fibrosis in atopic dermatitis J Biomed Opt 14 2009 014008
25. T. Hirao, T. Terui, I. Takeuchi, H. Kobayashi, M. Okada, and M. Takahashi Ratio of immature cornified envelopes does not correlate with parakeratosis in inflammatory skin disorders Exp Dermatol 12 2003 591 601
26. E.M. Peters, M.E. Ericson, J. Hosoi, K. Seiffert, M.K. Hordinsky, and J.C. Ansel Neuropeptide control mechanisms in cutaneous biology: physiological and clinical significance J Invest Dermatol 126 2006 1937 1947
27. D. Roggenkamp, S. Köpnick, F. Stäb, H. Wenck, M. Schmelz, and G. Neufang Epidermal nerve fibers modulate keratinocyte growth and differentiation via neuropeptide signaling in an innervated skin model J Invest Dermatol 2013 [Epub ahead of print]
28. J. Esparza-Gordillo, S. Weidinger, R. Folster-Holst, A. Bauerfeind, F. Ruschendorf, and G. Patone A common variant on chromosome 11q13 is associated with atopic dermatitis Nat Genet 41 2009 596 601
29. M.D. Howell, B.E. Kim, P. Gao, A.V. Grant, M. Boguniewicz, and A. De Benedetto Cytokine modulation of atopic dermatitis filaggrin skin expression J Allergy Clin Immunol 120 2007 150 155
30. C. Cornelissen, Y. Marquardt, K. Czaja, J. Wenzel, J. Frank, and J. Luscher-Firzlaff IL-31 regulates differentiation and filaggrin expression in human organotypic skin models J Allergy Clin Immunol 129 2012 426 433 e1-8
31. A. Szabowski, N. Maas-Szabowski, S. Andrecht, A. Kolbus, M. Schorpp-Kistner, and N.E. Fusenig c-Jun and JunB antagonistically control cytokine-regulated mesenchymal-epidermal interaction in skin Cell 103 2000 745 755
32. D.P. Gearing The leukemia inhibitory factor and its receptor Adv Immunol 53 1993 31 58
33. G.S. Brown, M.A. Brown, D. Hilton, N.M. Gough, and M.J. Sleigh Inhibition of differentiation in a murine F9 embryonal carcinoma cell subline by leukemia inhibitory factor (LIF) Growth Factors 7 1992 41 52
34. T. Adachi, H. Takanaga, M. Kunimoto, and H. Asou Influence of LIF and BMP-2 on differentiation and development of glial cells in primary cultures of embryonic rat cerebral hemisphere J Neurosci Res 79 2005 608 615
35. J. Elliott, M. Cayouette, and C. Gravel The CNTF/LIF signaling pathway regulates developmental programmed cell death and differentiation of rod precursor cells in the mouse retina in vivo Dev Biol 300 2006 583 598
36. P. Murray, and D. Edgar The regulation of embryonic stem cell differentiation by leukaemia inhibitory factor (LIF) Differentiation 68 2001 227 234
37. P. Xie, F.S. Chan, N.Y. Ip, and M.F. Leung Induction of gp130 and LIF by differentiation inducers in human myeloid leukemia K562 cells Leuk Res 23 1999 1113 1119
38. P.J. Hauser, D. Agrawal, J. Hackney, and W.J. Pledger STAT3 activation accompanies keratinocyte differentiation Cell Growth Differ 9 1998 847 855
39. R. Wu, S. Sun, and B.M. Steinberg Requirement of STAT3 activation for differentiation of mucosal stratified squamous epithelium Mol Med 9 2003 77 84
40. K. Boniface, C. Diveu, F. Morel, N. Pedretti, J. Froger, and E. Ravon Oncostatin M secreted by skin infiltrating T lymphocytes is a potent keratinocyte activator involved in skin inflammation J Immunol 178 2007 4615 4622
41. S. Braunstein, G. Kaplan, A.B. Gottlieb, M. Schwartz, G. Walsh, and R.M. Abalos GM-CSF activates regenerative epidermal growth and stimulates keratinocyte proliferation in human skin in vivo J Invest Dermatol 103 1994 601 604
42. M. Hernandez-Quintero, and W. Kuri-Harcuch Gonzalez Robles A, Castro-Munozledo F. Interleukin-6 promotes human epidermal keratinocyte proliferation and keratin cytoskeleton reorganization in culture Cell Tissue Res 325 2006 77 90
43. M. Zhu, K. Oishi, S.C. Lee, and P.H. Patterson Studies using leukemia inhibitory factor (LIF) knockout mice and a LIF adenoviral vector demonstrate a key anti-inflammatory role for this cytokine in cutaneous inflammation J Immunol 166 2001 2049 2054
44. L.R. Banner, P.H. Patterson, A. Allchorne, S. Poole, and C.J. Woolf Leukemia inhibitory factor is an anti-inflammatory and analgesic cytokine J Neurosci 18 1998 5456 5462
45. D. Langlais, C. Couture, A. Balsalobre, and J. Drouin Regulatory network analyses reveal genome-wide potentiation of LIF signaling by glucocorticoids and define an innate cell defense response PLoS Genet 4 2008 e1000224